Published in PLoS One on May 05, 2010
Meta-analysis of the relationship between Parkinson disease and melanoma. Neurology (2011) 1.45
Parkinson's disease and cancer: two wars, one front. Nat Rev Cancer (2011) 1.45
Improved immunodetection of endogenous α-synuclein. PLoS One (2011) 1.25
The role of alpha-synuclein in melanin synthesis in melanoma and dopaminergic neuronal cells. PLoS One (2012) 0.98
A new method for quantitative immunoblotting of endogenous α-synuclein. PLoS One (2013) 0.95
Increased neuronal α-synuclein pathology associates with its accumulation in oligodendrocytes in mice modeling α-synucleinopathies. PLoS One (2012) 0.93
Role of Ser129 phosphorylation of α-synuclein in melanoma cells. J Cell Sci (2012) 0.87
α-Synuclein expression selectively affects tumorigenesis in mice modeling Parkinson's disease. PLoS One (2011) 0.84
Analysis of alpha-synuclein in malignant melanoma - development of a SRM quantification assay. PLoS One (2014) 0.82
The associations between Parkinson's disease and cancer: the plot thickens. Transl Neurodegener (2015) 0.81
Is the risk of motor neuron disease increased or decreased after cancer? An Australian case-control study. PLoS One (2014) 0.81
Chronic Inflammation Links Cancer and Parkinson's Disease. Front Aging Neurosci (2016) 0.81
The association between Parkinson's disease and melanoma: a systematic review and meta-analysis. Transl Neurodegener (2015) 0.80
Sensitive western blotting for detection of endogenous Ser129-phosphorylated α-synuclein in intracellular and extracellular spaces. Sci Rep (2015) 0.78
Parkinson's Disease: Assay of Phosphorylated α-Synuclein in Skin Biopsy for Early Diagnosis and Association with Melanoma. Brain Sci (2016) 0.78
Metabolites of purine nucleoside phosphorylase (NP) in serum have the potential to delineate pancreatic adenocarcinoma. PLoS One (2011) 0.78
A protein deep sequencing evaluation of metastatic melanoma tissues. PLoS One (2015) 0.77
Interaction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease. Biomolecules (2015) 0.77
Status of the Parkinson's disease gene family expression in non-small-cell lung cancer. World J Surg Oncol (2015) 0.75
Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease. Neurobiol Aging (2016) 0.75
A simple and sensitive method for the demonstration of norepinephrine-storing adrenomedullary chromaffin cells. Histochem Cell Biol (2012) 0.75
Parkinson disease (PARK) genes are somatically mutated in cutaneous melanoma. Neurol Genet (2016) 0.75
Alpha-synuclein contributes to malignant progression of human meningioma via the Akt/mTOR pathway. Cancer Cell Int (2016) 0.75
Tristetraprolin inhibits mitochondrial function through suppression of α-Synuclein expression in cancer cells. Oncotarget (2017) 0.75
Cutaneous melanoma. Lancet (2005) 3.94
Melanosomes--dark organelles enlighten endosomal membrane transport. Nat Rev Mol Cell Biol (2007) 3.19
Specification of catecholaminergic and serotonergic neurons. Nat Rev Neurosci (2002) 2.38
A role for alpha-synuclein in the regulation of dopamine biosynthesis. J Neurosci (2002) 2.37
Oculocutaneous albinism. Orphanet J Rare Dis (2007) 2.31
Family history of melanoma and Parkinson disease risk. Neurology (2009) 2.25
Atypical cancer pattern in patients with Parkinson's disease. Br J Cancer (2005) 1.72
Alpha-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells. J Cell Sci (2005) 1.53
Molecular mechanisms of alpha-synuclein neurodegeneration. Biochim Biophys Acta (2008) 1.51
Malignant melanoma and other types of cancer preceding Parkinson disease. Epidemiology (2006) 1.36
Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer (1999) 1.15
The melanocytic protein Melan-A/MART-1 has a subcellular localization distinct from typical melanosomal proteins. Traffic (2002) 1.10
Comparative analysis of the in vivo expression of tyrosinase, MART-1/Melan-A, and gp100 in metastatic melanoma lesions: implications for immunotherapy. J Immunother (1998) 1.06
Melanoma biomarkers: current status and vision for the future. Nat Clin Pract Oncol (2008) 1.05
Evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma: higher diagnostic accuracy with Melan-A and MART-1 compared with S-100 protein and HMB-45. Am J Surg Pathol (2001) 1.01
HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanoma. Hum Pathol (2004) 0.95
Histopathology report of cutaneous melanoma and sentinel lymph node in Europe: a web-based survey by the Dermatopathology Working Group of the European Society of Pathology. Virchows Arch (2009) 0.93
The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A). J Clin Pathol (2001) 0.91
Ubiquitination of E3 ubiquitin ligase TRIM5 alpha and its potential role. FEBS J (2008) 1.53
Improved immunodetection of endogenous α-synuclein. PLoS One (2011) 1.25
Autoantigen Ro52 is an E3 ubiquitin ligase. Biochem Biophys Res Commun (2005) 1.23
The transcription factor Sox9 is degraded by the ubiquitin-proteasome system and stabilized by a mutation in a ubiquitin-target site. Matrix Biol (2004) 1.15
Regulation of the NEDD8 conjugation system by a splicing variant, NUB1L. J Biol Chem (2003) 1.15
NUB1 suppresses the formation of Lewy body-like inclusions by proteasomal degradation of synphilin-1. Am J Pathol (2006) 1.14
The inherited blindness associated protein AIPL1 interacts with the cell cycle regulator protein NUB1. Hum Mol Genet (2002) 1.12
Ro52-mediated monoubiquitination of IKK{beta} down-regulates NF-{kappa}B signalling. J Biochem (2009) 1.11
NEDD8 protein is involved in ubiquitinated inclusion bodies. J Pathol (2003) 1.10
TRIM9, a novel brain-specific E3 ubiquitin ligase, is repressed in the brain of Parkinson's disease and dementia with Lewy bodies. Neurobiol Dis (2010) 1.08
UnpEL/Usp4 is ubiquitinated by Ro52 and deubiquitinated by itself. Biochem Biophys Res Commun (2006) 1.06
Inhibition of NEDD8-conjugation pathway by novel molecules: potential approaches to anticancer therapy. Mol Oncol (2012) 1.05
Role of the NF-kappaB signaling pathway and kappaB cis-regulatory elements on the IRF-1 and iNOS promoter regions in mycobacterial lipoarabinomannan induction of nitric oxide. Infect Immun (2003) 1.00
Downregulation of active IKK beta by Ro52-mediated autophagy. Mol Immunol (2010) 0.94
Oncogenic protein UnpEL/Usp4 deubiquitinates Ro52 by its isopeptidase activity. Biochem Biophys Res Commun (2006) 0.93
Dynamic movements of Ro52 cytoplasmic bodies along microtubules. Histochem Cell Biol (2009) 0.90
Role of Ser129 phosphorylation of α-synuclein in melanoma cells. J Cell Sci (2012) 0.87
pVHL-independent ubiquitination of HIF1alpha and its stabilization by cobalt ion. Biochem Biophys Res Commun (2003) 0.86
Immunohistochemical localization of NUB1, a synphilin-1-binding protein, in neurodegenerative disorders. Acta Neuropathol (2007) 0.86
Function and subcellular location of Ro52beta. Biochem Biophys Res Commun (2005) 0.85
Abolished interaction of NUB1 with mutant AIPL1 involved in Leber congenital amaurosis. Biochem Biophys Res Commun (2004) 0.85
Immunohistochemical analysis of Marinesco bodies, using antibodies against proteins implicated in the ubiquitin-proteasome system, autophagy and aggresome formation. Neuropathology (2011) 0.84
Negative regulation of NEDD8 conjugation pathway by novel molecules and agents for anticancer therapy. Curr Pharm Des (2013) 0.83
Interaction of NUB1 with the proteasome subunit S5a. Biochem Biophys Res Commun (2005) 0.82
Cytoplasmic relocation of Daxx induced by Ro52 and FLASH. Histochem Cell Biol (2010) 0.81
NUB1-mediated targeting of the ubiquitin precursor UbC1 for its C-terminal hydrolysis. Eur J Biochem (2004) 0.81
Synphilin-1-binding protein NUB1 is colocalized with nonfibrillar, proteinase K-resistant α-synuclein in presynapses in Lewy body disease. J Neuropathol Exp Neurol (2011) 0.79
Pathobiochemical effect of acylated steryl-β-glucoside on aggregation and cytotoxicity of α-synuclein. Neurochem Res (2011) 0.79
Ubiquitination of Ro52 autoantigen. Biochem Biophys Res Commun (2002) 0.79
Ubiquitin-related proteins in neuronal and glial intranuclear inclusions in intranuclear inclusion body disease. Pathol Int (2012) 0.77
A simple and sensitive method for the demonstration of norepinephrine-storing adrenomedullary chromaffin cells. Histochem Cell Biol (2012) 0.75
Functional studies of AIPL1: potential role of AIPL1 in cell cycle exit and/or differentiation of photoreceptors. Adv Exp Med Biol (2003) 0.75
Cobalt- and nickel-binding property of cullin-2. Biochem Biophys Res Commun (2002) 0.75